Today’s AI Top Pick: ENOV

9/15/2026 · Highly Shorted Undervalued screen · a free sample of K3vl4r’s AI-curated picks.

AI-ranked from a screened shortlist, with entry strategy, targets, and risks.

The desk streams live daily· see the schedule →

Today's pick · Highly Shorted UndervaluedENOVBUY NOW8.8 / 109/15/2026

Enovis is the cleanest setup on the board: multi-timeframe agreement is total (4h fc +46.9/+31.7/+35.7, 1d fc +22.8/+41.0/+60.1, 1wk fc +5.0/+69.6/+123.0), near_term_bullish is a max 1.0, and bullish_prob is 1.0. Crucially, we are NOT chasing — position in 21-bar range is 3.02% on 4h, 3.04% on 1d, and 0% on 1wk, with weekly drawdown at -36.63%. That is the textbook 'washed-out, mean-reversion + trend re-emergence' geometry the screener is designed to catch. Fundamentally it clears the shorted-value lens by a wide margin: fwdPe just 4.93 (cheapest in the entire pool), peg 0.71, analyst recom 1.23 (near strong-buy), and targetUpsidePct 110.4%. Yes, TTM profitMargin is -47.9% and roe -54.25, but the forward P/E of ~5 tells you the market already knows this is a post-restructuring, EPS-normalization story — that's precisely why short float is elevated at 16.17% and RSI sits at 31.66 (oversold). The setup pays you to be early. The tape is also being confirmed by the news flow, which is the tiebreaker: two separate insider-buy headlines within the last week (a director purchasing >7,500 shares and Oliver Engert adding 2,660 more). Insider accumulation into a 31% YTD drawdown and 42% one-year decline is the strongest possible qualitative confirmation of a bottoming process. Why today and not wait? Price is essentially pinned at the bottom of every intraday and daily range (pos 0-3%) with all three forecast horizons pointing up and short-horizon momentum still positive. Waiting for a 'pullback' from here means chasing the first 20-30% mean-reversion move. The asymmetric geometry — small distance to a logical stop, 110% analyst upside, insider buying — is the trade.

Entry zone

$18.00-$18.75 (scale in around current $18.47; add on any dip toward $17.75 which is the 4h low area)

Stop loss

$16.40 (below the 21-bar low; a clean break there invalidates the bottoming thesis and roughly -11% risk from entry)

First target

$22.75 (~+23%, aligns with 4h fc_short and closes the daily drawdown gap)

Longer target

$28-$31 (~+55-70%, tracks the 1wk mid/long forecast of +69/+123% and analyst target zone; would still leave room to the +110% consensus upside)

Risks

TTM profitMargin -47.9% and roe -54.25 — if the forward EPS ramp (fwdPe 4.93 implies a big jump) disappoints on next print, the shorts (16.17% float) get vindicated
debtEq 0.93 combined with negative TTM earnings means refinancing/interest coverage risk if rates stay elevated
Small-cap medical devices ($1.05B mkt cap) — thin liquidity can turn a -11% stop into a -15% gap on adverse news
salesYoY only +4.89% — the recovery is being priced in via margins, not top-line acceleration, so any GM slippage hits the multiple hard
1wk pos_in_range at 0% and dd -36.63% mean this could still be in the falling-knife phase; entry requires accepting the stock has been a serial disappointer

Honorable mentions

ADTNSimilar washed-out geometry (pos_in_range 0% across all TFs, 1wk dd -61.84%) with bullish_prob 1.0, near_term_bullish 1.0, fwdPe 12.09, peg 0.22, recom 1.44, and 108.8% target upside. Insider Monkey headline flags 'optical surge' as a positive catalyst. Slightly less forecast magnitude on mid/long weekly (+15/+26) vs ENOV keeps it at #2.

CWHExplosive forecasts (1wk fc_mid +143.9%, fc_long +190.8%) from a very low base (pos_in_range 0-19%) with bullish_prob 1.0. Held back by debtEq 15.21, negative TTM margins, and a Truist PT cut to $10 plus a bearish SA piece ('The Worst Isn't Over') — the setup is right but the news is a landmine, so BUY_PULLBACK rather than BUY_NOW.

Full ranking (15)

#	Symbol	Verdict	Score	Read
1	ENOV	BUY NOW	8.8	Full multi-TF alignment, cheapest fwdPe (4.93) in the pool, pos_in_range ~0-3%, and confirmed by two insider buys this week.
2	ADTN	BUY NOW	8.2	Bottom-of-range across all TFs with bullish_prob 1.0, near_term 1.0, fwdPe 12.09, and 108.8% analyst upside.
3	CWH	BUY PULLBACK	7.4	Massive 1wk forecasts (+143/+190%) from washed-out base, but Truist PT cut and bearish SA note argue for a lower entry.
4	RH	BUY NOW	7.2	1wk fc_long +132.5% with pos_in_range 0-14% and near_term_bullish 1.0; debtEq 34.14 is the reason it isn't #1.
5	AMRC	BUY NOW	6.9	Clean multi-TF setup (4h fc +40.7%, pos 2.97%) with fwdPe 13.56 and peg 0.33; slight demerit for the 'cash flow problem' headline today.
6	PAR	BUY PULLBACK	6.4	Strong forecasts (1d fc_long +144%, 1wk +115%) and near_term 0.8, but 4h pos_in_range 68.9% means wait for a dip.
7	EYE	BUY PULLBACK	5.7	Solid 4h/1d forecasts and pos_in_range 5-27%, but 1wk fc_short -8.6% and 'down 10.1% since earnings' argue for patience.
8	OWL	WAIT	5.0	1wk forecasts turn negative (-5.2/-8.4%) despite decent 1d setup; private-credit risk headlines add uncertainty.
9	EVH	WAIT	4.8	1wk fc_long +281% is eye-popping but 4h forecasts all negative and profitMargin -24.4% — signal is contradictory.
10	FOUR	WAIT	4.5	4h fc_mid/long -15/-24% contradicts the daily bullish read; wait for TF alignment.
11	CXT	WAIT	4.2	Forecast magnitudes tiny (fc_long +6.4% wk) and 'likely to remain cheap' SA headline — no urgency.
12	MNDY	WAIT	3.9	near_term_bullish only 0.2, 1h/4h fc negative, pos_in_range 74-81% — chasing the top.
13	NCNO	AVOID	3.5	pos_in_range 98.8% on 4h, 4h fc_mid -19%, bullish_prob 0 — textbook chase.
14	GPGI	AVOID	3.0	1wk fc_mid/long -24.8/-29.0% and headline flags lawsuits + lowered 2026 guidance.
15	ARDT	AVOID	2.7	pos_in_range 100% on 4h with bullish_prob 0 and 4h/1d forecasts all negative — broken setup at the top.

Get AI top picks & forecasts on any stock

K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord